Drug Shortage Report for VINCRISTINE SULFATE INJECTION

Last updated on 2019-11-29 History
Report ID 99955
Drug Identification Number 02143305
Brand name VINCRISTINE SULFATE INJECTION
Common or Proper name VINCRISTINE INJECTION 1MG/ML
Company Name TEVA CANADA LIMITED
Active Ingredient(s) VINCRISTINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2ML
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28
Estimated end date 2020-01-31
Actual end date
Shortage status Actual shortage
Updated date 2019-11-29
Company comments
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2019-11-29 English Compare
v3 2019-11-28 French Compare
v2 2019-11-28 English Compare
v1 2019-11-28 English Compare